NATCO Pharma Limited (NSE:NATCOPHARM)

NATCO Pharma Revenue

NATCO Pharma had revenue of 13.63B INR in the quarter ending September 30, 2025, a decrease of -0.59%. This brings the company's revenue in the last twelve months to 43.90B, down -3.81% year-over-year. In the fiscal year ending March 31, 2025, NATCO Pharma had annual revenue of 44.32B with 10.74% growth.

• Revenue (ttm): 43.90B
• Revenue Growth: -3.81%
• P/S Ratio: 3.53
• Revenue / Employee: 10.46M
• Employees: 4,199
• Market Cap: 154.89B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	44.32B	4.30B	10.74%
Mar 31, 2024	40.02B	12.94B	47.76%
Mar 31, 2023	27.09B	7.62B	39.17%
Mar 31, 2022	19.46B	-1.10B	-5.35%
Mar 31, 2021	20.56B	1.41B	7.37%